Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-104,682
Closed -$13.8M 83
2024
Q1
$13.8M Sell
104,682
-6,435
-6% -$793K 0.78% 42
2023
Q4
$12.1M Sell
111,117
-12,223
-10% -$1.27M 0.86% 32
2023
Q3
$12.7M Buy
123,340
+19,183
+18% +$2.07M 1.18% 21
2023
Q2
$12M Sell
104,157
-16,733
-14% -$1.9M 1.05% 25
2023
Q1
$12.9M Buy
120,890
+4,675
+4% +$505K 0.94% 28
2022
Q4
$12.9M Buy
116,215
+66,226
+132% +$6.77M 1.09% 25
2022
Q3
$4.31M Buy
+49,989
New +$4.46M 0.35% 62
2014
Q2
Sell
-7,889
Closed -$427K 49
2014
Q1
$427K Buy
+7,889
New +$409K 0.05% 41

Other funds holding MRK

Formuepleje A/S's MRK Position: Q2 2024 in Review

Formuepleje A/S sold out of Merck (MRK) in Q2 2024, closing a stake of 104,682 shares — an estimated $13.8M sold.

Formuepleje A/S first reported a position in MRK in Q1 2014 and held it in 8 quarters. The position peaked at $13.8M in Q1 2024. 3,551 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Formuepleje A/S reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Formuepleje A/S sold 104,682 Merck shares in Q2 2024, an estimated $13.8M.
  • Formuepleje A/S first reported a position in Merck in Q1 2014 and held it in 8 quarters.
  • Formuepleje A/S's Merck position peaked at $13.8M in Q1 2024.
  • 3,551 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Formuepleje A/S's 13F filing for Q2 2024, filed 27 Aug 2026.